The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

被引:2
|
作者
Braune, Stefan [1 ]
Bluemich, Sandra [2 ]
Bruns, Carola [2 ]
Dirks, Petra [3 ]
Hoffmann, Jeanette [2 ]
Heer, Yanic [4 ]
Rouzic, Erwan Muros-Le [3 ]
Bergmann, Arnfin [1 ]
机构
[1] NeuroTransData, Neuburg An Der Donau, Germany
[2] Roche Pharm AG, Grenzach Wyhlen, Germany
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
[4] PricewaterhouseCoopers PwC, Zurich, Switzerland
关键词
Primary progressive multiple sclerosis; Natural history; Retrospective study; Cohort studies; Quality of life; BURDEN; ONSET; MS;
D O I
10.1186/s12883-023-03273-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundPrimary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited.MethodsPPMS patients from the German NeuroTransData (NTD) MS registry with data from 56 outpatient practices were employed for retrospective cross-sectional and longitudinal analyses. The cross-sectional analysis included a contemporary PPMS cohort with a documented visit within the last 2 years before index date (1 Jan 2021). The longitudinal analysis included a disease modifying therapy (DMT)-naive population and focused on the evolution of expanded disability status scale (EDSS) from the first available assessment at or after diagnosis within the NTD registry to index date. Outcome measures were estimated median time from first EDSS assessment to first 24-week confirmed EDSS & GE; 4 and & GE; 7. Besides EDSS change, the proportion of patients on disability pension were described over time.ResultsThe cross-sectional analysis included 481 PPMS patients (59.9% female, mean [standard deviation, SD] age 60.5 [11.5] years, mean [SD] EDSS 4.9 [2.1]). Estimated median time from first EDSS assessment after diagnosis to reach 24-week confirmed EDSS & GE; 4 for DMT-naive patients was 6.9 years. Median time to EDSS & GE; 7 was 9.7 years for 25% of the population. Over a decade mean (SD) EDSS scores increased from 4.6 (2.1) to 5.7 (2.0); the proportion of patients on disability pension increased from 18.9% to 33.3%.ConclusionsThis study provides first insights into the German NTD real-world cohort of PPMS patients. Findings confirm the steadily deteriorating course of PPMS accompanied by increasingly limited quality of life.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] NEUROPSYCHOLOGY OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
    Paes, R. A.
    Alvarenga, R. M. P.
    Vasconcelos, C. C. F.
    Negreiros, M. A.
    Landeira-Fernandez, J.
    REVISTA DE NEUROLOGIA, 2009, 49 (07) : 343 - 348
  • [32] The natural history of multiple sclerosis
    G.C. Ebers
    Neurological Sciences, 2000, 21 (Suppl 2) : S815 - S817
  • [33] Natural history of multiple sclerosis
    Bonek, Robert
    Maciejek, Zdzislaw
    AKTUALNOSCI NEUROLOGICZNE, 2009, 9 (02): : 116 - 125
  • [34] The natural history of multiple sclerosis
    Kremenchutzky, M
    REVISTA DE NEUROLOGIA, 2000, 30 (10) : 967 - 972
  • [35] The search for responsive clinical endpoints in primary progressive multiple sclerosis
    Bosma, L. V. A. E.
    Kragt, J. J.
    Brieva, L.
    Khaleeli, Z.
    Montalban, X.
    Polman, C. H.
    Thompson, A. J.
    Tintore, M.
    Uitdehaag, B. M. J.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (06) : 715 - 720
  • [36] Disease onset in familial and sporadic primary progressive multiple sclerosis
    Koch, M.
    Zhao, Y.
    Yee, I.
    Guimond, C.
    Kingwell, E.
    Rieckmann, P.
    Sadovnick, D.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 694 - 700
  • [37] Primary progressive multiple sclerosis: progress and challenges
    Rice, Claire M.
    Cottrell, David
    Wilkins, Alastair
    Scolding, Neil J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (10) : 1100 - 1106
  • [38] The MRZ reaction in primary progressive multiple sclerosis
    Tilman Hottenrott
    Rick Dersch
    Benjamin Berger
    Sebastian Rauer
    Daniela Huzly
    Oliver Stich
    Fluids and Barriers of the CNS, 14
  • [39] Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis
    Ferreira Vasconcelos, Claudia Cristina
    Fernandez, Oscar
    Leyva, Laura
    Santos Thuler, Luiz Claudio
    Papais Alvarenga, Regina Maria
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 214 (1-2) : 101 - 103
  • [40] Genetics and natural history of multiple sclerosis
    Kantarci, Orhun H.
    SEMINARS IN NEUROLOGY, 2008, 28 (01) : 7 - 16